Clinical Features, Predisposing Factors, and Treatment Outcomes of Scleritis in the Korean Population
Author:
Affiliation:
1. Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea.
2. Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Seoul, Korea.
Publisher
Korean Ophthalmological Society
Subject
General Medicine
Link
https://synapse.koreamed.org/pdf/10.3341/kjo.2010.24.6.331
Reference19 articles.
1. Evaluation of patients with scleritis for systemic disease
2. Severity of Scleritis and Episcleritis
3. Progression of Scleral Disease
4. EPISCLERITIS AND SCLERITIS. I
5. Sderitis Associated with Rheumatoid Arthritis and with Other Systemic Immunemediated Diseases
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Treatment options for necrotizing scleritis in rheumatoid arthritis patients;Expert Review of Ophthalmology;2024-07-23
2. Long-Term Outcome of Tofacitinib Treatment for Systemic Autoimmune Disease-Associated Refractory Scleritis;Ocular Immunology and Inflammation;2024-05-31
3. Clinical Course and Outcomes of Autoimmune Versus Non-Autoimmune Surgically Induced Scleral Necrosis: A Multicentric Comparative Study;Ocular Immunology and Inflammation;2024-05-17
4. Hemophilus influenzae-associated scleritis – A case report with a review of the literature;Indian Journal of Ophthalmology - Case Reports;2024-04
5. Scleritis and Development of Immune-Mediated Disease: A Retrospective Chart Review;The Journal of Rheumatology;2024-02-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3